Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-007514
Filing Date
2011-11-21
Accepted
2011-11-21 17:00:38
Documents
1
Period of Report
2011-11-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT c67633_form4.html 4  
1 OWNERSHIP DOCUMENT c67633_form4.xml 4 6667
  Complete submission text file 0000930413-11-007514.txt   8417
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CHAMPIONS BIOTECHNOLOGY, INC. 855 NORTH WOLFE STREET, SUITE 619 BALTIMORE MD 21205
Business Address
Stancic Ana (Reporting) CIK: 0001320271 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 111219608